Management of mycoses associated with HIV disease

International Journal of STD and AIDS

Volumn 6, Issue 6, 1995, Pages 408-412

  Coker, R J ^a   Fisher, M ^a   Tomlinson, D R ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

HIV; Mycoses

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; TERBINAFINE;

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MYCOSIS; PRIORITY JOURNAL; REVIEW;

EID: 0029584712     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/095646249500600605     Document Type: Article

References (22)

1. Bossche H., Vanden, Mackenzie DWR, Cauwenbergh G, Van Cutsem J, Drouhet E, Dupont B, eds. Mycoses in AIDS patients. Plenum Press, London: 1990.
2. Cunliffe N.A., Denning D.W., Uncommon invasive mycoses in AIDS. AIDS 1995; 9: 411–420.
3. Rex J.H., Rinaldi M.G., Pfaller M.A., Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 39: 1–8.
4. Coker R.J., Cryptococcal infection in AIDS. Int J STD AIDS 1992; 3: 168–172.
5. Sugar A.M., Stern J.J., Dupont B. Treatment of cryptococcal meningitis. Rev Infect Dis 1990; 12 (Suppl 3):S338–S348.
6. Reichert C.M., O'Leary T.J., Levens D.L., Simrell C.R., Macher A.M., Autopsy pathology in the acquired immune deficiency syndrome. Am J Pathol 1983; 112: 357–382.
7. Welch K., Finkbeiner W., Alpers C.E., et al, Autopsy findings in the acquired immune deficiency syndrome. JAMA 1984; 252: 1152–1159.
8. Holmberg K., Meyer R.D., Fungal infections in patients with AIDS and AIDS related complex. Scand J Infect Dis 1986; 18: 179–192.
9. Rex J.H., Rinaldi M.G., Pfaller M.A., Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 39: 1–8.
10. Torssander J., Karlson A., Morfeldt-Manson L., Putkonen P., Wasserman J. Dermatophytosis and HIV infection—a study in homosexual men. Acta Dematovenereol 1988; 68: 53.
11. Valle S.L., Dermatologic findings related to human immunodeficiency virus infection in high-risk individuals. J Am Acad Dermatol 1987; 17: 951–961.
12. Selik R.M., Starcher E.T., Curran J.W., Opportunistic diseases reported in AIDS patients: Frequencies, associations, and trends. AIDS 1987; 1: 175–182.
13. Bozette S.A., Larsen R.A., Chin J, et al, A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 580–584.
14. Zugar A., Louie E., Holzmann R.S., Simberkoff M.S., Rachal J.J., Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med 1986; 104: 234.
15. Chuck S.L., Sande M.A., Infection with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321: 794.
16. Saag M.S., Powderly W.G., Cloud G.A., et al, Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1993; 326: 83–89.
17. Coker R.J., Tomlinson D.R., Parkin J., Harris J.R.W. Pinching A.J., Interaction between fluconazole and rifampicin. BMJ 1990; 301: 818.
18. de Gans J., Portegies P., Tiessens G, et al, Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 1992; 6: 185–190.
19. Coker R.J., Viviani M., Gazzard B.G., et al, Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS; 7: 829–835.
20. Fisher M., Price D.A., Klein J., Weston R., Coker R.J., Cryptococcal disease in HIV infection: Treatment and maintenance. AIDS 1995; 9: 300–301.
21. Witt M.D., Mortara L.A., Larsen R.A., Lewis R.J., Edwards J.E., Ghannaum M.A., In vitro susceptibility of cryptococcus neoformans predicts failure of primary therapy with fluconazole in patients with cryptococcal meningitis and AIDS. In: Proceedings of the IX International Conference on AIDS Abstr. WS-B12–4 1993.
22. Powderly W.G., Finkelstein D., Feinberg J, et al, A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995; 332: 700–705.